期刊文献+

人端粒酶与RNA模板的共表达及纯化

Co-expression and purification of the human telomerase with the RNA template
原文传递
导出
摘要 [目的]提高人端粒酶的表达量和可溶性,获得可溶性的人端粒酶。[方法]分别构建融合质粒pRT-ppSUMO和RNA质粒hTER-puc19,共同转化至大肠杆菌BL21(DE3)中,并优化共表达条件,通过亲和层析分离纯化得到人端粒酶。[结果]人端粒酶和RNA模板共表达体系将人端粒酶的表达水平提高了1.49倍;确定共表达中最佳IPTG诱导浓度为0.75mmol/L,最佳诱导温度为20℃,诱导时间为12~16h;经纯化最终得到浓度为29.61μg/mL,纯度为70%的人端粒酶。[结论]得到可溶性人端粒酶,可用于其晶体结构及功能的进一步研究。 [Objective]To improve the expression level and solubility of human telomerase,and obtain the soluble protein.[Methods]pRT-ppSUMO fusion plasmid and the hTER-puc19 RNA plasmid were separately constructed,and both co-transformed into E.coli BL21(DE3)cells,then the co-expression conditions were optimized and the target protein was purified by affinity chromatography.[Results]The co-expression system of the human telomerase with the RNA template increased human telomerase expression by 1.49 times;the optimum concentration of IPTG induction was 0.75 mmol /L and the optimum inducing temperature was 20℃ for 12-16 h;the resulting concentration of human telomerase after purification was 29.61 μg /mL,and the purity was 70%.[Conclusion]The soluble protein human telomerase was obtained,which could support further studies of its crystal structure and function.
作者 方迷 张敏敏 杨卓茹 陈婷 张云龙 陆昌瑞 Mi Fang;Minmin Zhang;Zhuoru Yang;Ting Chen;Yunlong Zhang;Changrui Lu(College of Chemistry,Chemical Engineering and Biotechnology,Donghua University,Shanghai 201620,China)
出处 《生物技术》 CAS 2018年第6期520-525,共6页 Biotechnology
基金 国家自然科学基金项目(“SAM核酸开关的结构与机理”,No.31300603)
关键词 人端粒酶 人端粒酶RNA 共表达 蛋白纯化 human telomerase hTER co-expression protein purification
  • 相关文献

参考文献3

二级参考文献21

  • 1Yan-Fang Yu,Yong Zhang,Na Shen,Rui-Ying Zhang,Xin-Qing Lu.Effect of VEGF,P53 and telomerase on angiogenesis of gastric carcinoma tissue[J].Asian Pacific Journal of Tropical Medicine,2014,7(4):293-296. 被引量:15
  • 2Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet, 1987, 2(8571): 1300-1304.
  • 3Vahl TP, PaW BW, Fuller BD, et al. Effects of GLP-1-(7-36)NH2, GLP-I-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. Clin Endocrinol Metab, 2003, 88(4): 1772-1779.
  • 4Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996, 379(4): 69-72.
  • 5Ahr6n B, Winzell MS, Wierup N, et al. Hughes, DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose inassociation with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide. Regul Pept, 2007, 143(1/3): 97-103.
  • 6Deacon CF, Johnsen AH, Hoist JJ. Degradation ofglucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a majorendogenous metabolite in vivo. Clin Endocrinol Metab, 1995, 80(3): 952-957.
  • 7Dou WF, Lei JY, Zhang LF, et al. Expression, purification, and characterization of recombinant human serum albumin fusion protein with two human glucagon-like peptide-1mutants in Pichia pastoris. Protein Expr Purif, 2008, 61(1): 45-49.
  • 8Williams KE, Jiang J, Ju J, et al. Novel strategies for increased copy number and expression of recombinant human gelatin in Pichia pastoris with two antibioticmarkers. Enzyme Microbial Technol, 2008, 43(1): 31-34.
  • 9Lin-cereghino J, Wong WW, Xiong S, et al. Condensedprotocol for competent cell preparation and transformation of the methylotrophic yeast Pichia pastoris. Biotechniques, 2005, 38(1): 44-48.
  • 10Mcgrew JT, leiske D, Dell B, et al. Expression of trimeric CD40 ligand in Pichia pastoris: used of a rapid method to detect high-level expressing teansformants. Gene, 1997, 187(2): 193-200.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部